Patents by Inventor Kuo-Chi Cheng

Kuo-Chi Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11984649
    Abstract: A wearable device includes a conducting frame, a circuit board, and a grounding member. The conducting frame includes a first part and a second part that are separated. The circuit board has a system grounding surface and is disposed inside the conducting frame. The grounding member is disposed inside the conducting frame and connected to the first part. The first part and the grounding member are formed as a first antenna. The first part has a first feeding terminal. The grounding member has a first grounding terminal, and the first grounding terminal is connected to the system grounding surface of the circuit board. The second part is formed as a second antenna. The second antenna has a second feeding terminal, a second grounding terminal, and a third grounding terminal. The second and the third grounding terminals are connected to the system grounding surface of the circuit board.
    Type: Grant
    Filed: May 6, 2022
    Date of Patent: May 14, 2024
    Assignee: PEGATRON CORPORATION
    Inventors: Kuo-Chi Cheng, Po-Yen Lai, Ping-Hung Lu
  • Publication number: 20230097880
    Abstract: A wearable device includes a conducting frame, a circuit board, and a grounding member. The conducting frame includes a first part and a second part that are separated. The circuit board has a system grounding surface and is disposed inside the conducting frame. The grounding member is disposed inside the conducting frame and connected to the first part. The first part and the grounding member are formed as a first antenna. The first part has a first feeding terminal. The grounding member has a first grounding terminal, and the first grounding terminal is connected to the system grounding surface of the circuit board. The second part is formed as a second antenna. The second antenna has a second feeding terminal, a second grounding terminal, and a third grounding terminal. The second and the third grounding terminals are connected to the system grounding surface of the circuit board.
    Type: Application
    Filed: May 6, 2022
    Publication date: March 30, 2023
    Applicant: PEGATRON CORPORATION
    Inventors: Kuo-Chi Cheng, Po-Yen Lai, Ping-Hung Lu
  • Patent number: 8048663
    Abstract: The present invention relates to Pregnane X receptor (PXR) polypeptides and crystals that are useful, for example, for crystallization and in assays for identification of modulators of PXR.
    Type: Grant
    Filed: June 15, 2010
    Date of Patent: November 1, 2011
    Assignee: Schering Corp.
    Inventors: Wenyan Wang, Shahriar Shane Taremi, Winifred Prosise, Paul Reichert, Charles A. Lesburg, Vincent S. Madison, Kuo-Chi Cheng
  • Publication number: 20100286372
    Abstract: The present invention relates, inter alia, to PXR polypeptides and crystals that are useful, for example, for crystallization and in assays for identification of modulators of PXR.
    Type: Application
    Filed: June 15, 2010
    Publication date: November 11, 2010
    Applicant: Schering Corporation
    Inventors: Wenyan Wang, Shahriar Shane Taremi, Winifred Prosise, Paul Reichert, Charles A. Lesburg, Vincent S. Madison, Kuo-Chi Cheng
  • Patent number: 7785879
    Abstract: The present invention relates, inter alia, to PXR polypeptides and crystals that are useful, for example, for crystallization and in assays for identification of modulators of PXR.
    Type: Grant
    Filed: September 18, 2006
    Date of Patent: August 31, 2010
    Assignee: Schering Corporation
    Inventors: Wenyan Wang, Shahriar Shane Taremi, Winifred W. Prosise, Paul Reichert, Charles A. Lesburg, Vincent S. Madison, Kuo-Chi Cheng
  • Publication number: 20070021351
    Abstract: Compositions and therapeutic combinations are provided including at least one compound selected from the group consisting of compounds of Formulae I to XXVI as defined herein as well as methods of treatment, prevention or amelioration of one or more symptoms of hepatitis C, treating disorders associated with HCV virus, modulating activity of HCV protease, in which liver to plasma concentration ratio of the compound ranges from about 2:1 to about 10:1.
    Type: Application
    Filed: May 31, 2006
    Publication date: January 25, 2007
    Inventors: Ronald White, Kuo-Chi Cheng